IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

B Group, Inc.

Q4 2024 Holdings

Filed 2025-02-14 | 18 holdings | $163.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Invesco QQQ TRPUT46090E953$56.2M110,00034.4%
Adma Biologics Inc(ADMA)COM000899104$39.2M2,287,54224.0%
Insmed Inc(INSM)COM PAR $.01457669307$24.2M350,00014.8%
ZAI LAB LTD(ZLAB)ADR98887Q104$10.5M400,0006.4%
Iovance Biotherapeutics Inc(IOVA)COM462260100$7.3M992,0004.5%
Akero Therapeutics Inc(AKRO)COM00973Y108$7.2M260,0004.4%
Cellectis S A(CLLS)SPON ADS15117K103$5.5M3,081,5013.4%
Aura Biosciences Inc(AURA)COM05153U107$3.9M472,5762.4%
Sight Sciences Inc(SGHT)COM82657M105$2.3M629,3701.4%
Taysha Gene Therapies Inc(TSHA)COM SHS877619106$1.7M965,5561.0%
Ultragenyx Pharmaceutical inCALL90400D908$1.2M29,5000.8%
Spyre Therapeutics Inc(SYRE)COM NEW00773J202$1.2M50,0000.7%
Assembly Biosciences Inc(ASMB)COM NEW045396207$799.3K50,6510.5%
Apogee Therapeutics Inc(APGE)COM03770N101$679.5K15,0000.4%
Corvus Pharmaceuticals IncPUT221015950$535.0K100,0000.3%
Biontech SE(BNTX)SPONSORED ADS09075V102$398.8K3,5000.2%
Oruka Therapeutics Inc(ORKA)COM687604108$387.8K20,0000.2%
Ultragenyx Pharmaceutical in(RARE)COM90400D108$319.6K7,5960.2%